Skip to main content
. 2019 Dec 7;39(1):169–177. doi: 10.1007/s10096-019-03708-7

Fig. 1.

Fig. 1

Percentage prevalence by country of C. difficile PCR ribotypes in a year 1, b year 2, c year 3, d year 4 and e year 5 of the ClosER study. aNo submissions received from this country. Other = all other ribotypes with prevalence < 1%